PYXS

Conviction 69HealthcareScan · Thu, Jun 25, 2026

PYXS$2.23+2.76%

ResistanceSupportVol 14

Vol MA14 503.55K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Pyxis Oncology, Inc.PHARMACEUTICAL PREPARATIONSwww.pyxisoncology.com ↗

Price2.23

Change+2.76%

Gap+3.23%

Rel volume1.80×

Avg volume471.86K

Avg $ vol885.55K

SMA 201.84

SMA 501.92

SMA 2002.30

Price vs 50+16.32%

Price vs 200-3.22%

MA stackmixed

50/200 cross—

Supertrendup · 1.63

RSI (14)66

MACD hist0.06

MACD crossbull · 5d

Stoch %K / %D90 / 83

ADX (14)20

+DI / −DI25 / 11

RSI divergence—

MACD divergence—

ATR %+8.75%

ADR %9.11%

52w high5.34

52w low1.04

From 52w high-58.24%

Above 52w low+114.42%

New 52w highNo

SqueezeOff

Bollinger width38.92%

%B1.04

Donchian pos90.20%

Donchian high2.31

Donchian low1.54

AVWAP (52w high)1.87

vs AVWAP high+19.13%

AVWAP (52w low)2.20

vs AVWAP low+1.14%

OBV trendUp

Chaikin MF (20)0.13

Today vs 20d1.80×

Avg vol (14d)503.55K

Avg vol (20d)471.86K

Avg $ vol (20d)885.55K

Market cap141.28M

RS 3m (vs SPY)+47.30%

RS 6m (vs SPY)+62.46%

RS line new highNo

Trend template4/8

Technical rank74.8

1 week+17.37%

1 month+36.81%

3 months+55.94%

6 months+87.39%

1 year+74.22%

YTD+93.91%

P/E-1.77

P/B4.52

P/S10.20

P/FCF-2.22

EPS-1.28

Div yield—

ROE-254.64%

ROA-123.83%

Debt/Eq—

Current2.76

EV/EBITDA-1.70

Gross margin—

Net margin-574.55%

Rev growth-14.17%

EPS growth-2.96%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value135.52M

Revenue2.82M

Net income-23.27M

Gross profit—

Free cash flow-63.51M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out63.36M

Employees56

ListedFri, Oct 8, 2021

Free float41.37M

Float %66.5%

Short interest1.74M

Days to cover2.9d

Short volume51.6%

Squeeze score43 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction69 / 100

Pattern quality—

Tech rank74.8 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.40

Support1.56

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PYXS

All disclosures →

No recent disclosed trades by Congress in PYXS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PYXS

No recent insider (Form 4) filings in PYXS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in PYXS · 1 recent

EDGAR →

8-K8-KMon, Jun 15, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.